Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

BACKGROUND: The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamias, Aristotelis, Karadimou, Alexandra, Lampaki, Sofia, Lainakis, George, Malettou, Lia, Timotheadou, Eleni, Papazisis, Kostas, Andreadis, Charalambos, Kontovinis, Loukas, Anastasiou, Ioannis, Stravodimos, Kostas, Xanthakis, Ioannis, Skolarikos, Andreas, Christodoulou, Christos, Syrigos, Kostas, Papandreou, Christos, Razi, Evangelia, Dafni, Urania, Fountzilas, George, Dimopoulos, Meletios A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837011/
https://www.ncbi.nlm.nih.gov/pubmed/20163744
http://dx.doi.org/10.1186/1471-2407-10-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837011/
https://www.ncbi.nlm.nih.gov/pubmed/20163744
http://dx.doi.org/10.1186/1471-2407-10-45

Ejemplares similares